Kaken Pharmaceutical Competitors and Similar CompaniesClear all

Kaken Pharmaceutical's competitors and similar companies include Oasis Medical, JETEMA, Nippon Chemiphar and Kaleo.

	Kaken Pharmaceutical Kaken Pharmaceutical is a company providing pharmaceuticals and medical devices in the orthopedics and dermatology fields.	Oasis Medical OASIS Medical is a company that specializes in eye care solutions.	JETEMA JETEMA (제테마, formerly known as Pronexx) is a company that specializes in the research and development of medicines and medical devices.	Nippon Chemiphar Nippon Chemiphar is a pharmaceutical company that specializes in the development of generic drugs.	Kaleo Kaléo is a company that specializes in human factors engineering and drug-device combination product development.
Founding Date	Founding Date 1948	Founding Date 1987	Founding Date 2009	Founding Date 1950	Founding Date 2005
Type	Type Public	Type Private	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development medical devices pharma	Tags Healthcare biotech drug development medical devices pharma	Tags Healthcare biotech drug development medical devices pharma	Tags Healthcare biotech drug development medical devices pharma	Tags Healthcare biotech healthtech medical devices pharma
Locations	Locations Bunkyo City, JP HQ	Locations Glendora, US HQ San Dimas, US	Locations Weonju, KR HQ Yongin Si, KR Rayong, TH	Locations Chiyoda City, JP HQ Fukuoka, JP Osaka, JP Saitama, JP Sapporo, JP Sendai, JP	Locations Richmond, US HQ
Employees	Employees 1,135	Employees 1452% increase	Employees 227	Employees 887	Employees 1222% decrease
Valuation ($)	Valuation ($) 961.7 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 34.7 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) ¥76.9b (FY, 2026)	Revenue (est.) N/A	Revenue (est.) ₩68.5b (FY, 2024)	Revenue (est.) ¥33.1b (FY, 2026)	Revenue (est.) N/A
Cost of goods	Cost of goods ¥34.3b (FY, 2026)	Cost of goods N/A	Cost of goods ₩28.2b (FY, 2024)	Cost of goods ¥23.1b (FY, 2026)	Cost of goods N/A
Gross profit	Gross profit ¥42.6b (FY, 2026)	Gross profit N/A	Gross profit ₩40.7b (FY, 2024)	Gross profit ¥10b (FY, 2026)	Gross profit N/A
Net income	Net income ¥2.1b (FY, 2026)	Net income N/A	Net income (₩2.6b) (FY, 2024)	Net income ¥198m (FY, 2026)	Net income N/A